Amedisys Announces Second Quarter Earnings Release and Conference Call Date
July 19 2017 - 2:30PM
Amedisys, Inc. (NASDAQ:AMED), announced today that it will report
results for the second quarter ended June 30, 2017 after the market
closes on July 26, 2017. The Company will host an investor
conference call to discuss these results at 11:00 a.m. ET on July
27, 2017.
To participate on the conference call, please call a few minutes
before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412)
902-1028 (Toll). A replay of the conference call will be
available through August 27, 2017. The replay dial-in number
is (877) 660-6853 (Toll-Free) or (201) 612-7415 (Toll) and
reference conference ID #13666366.
A live webcast of the call will be accessible
through our website on our Investor Relations section at the
following web address: http://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. is a leading healthcare at home
Company delivering personalized home health, hospice and personal
care. Amedisys is focused on delivering the care that is best for
our patients, whether that is home-based personal care; recovery
and rehabilitation after an operation or injury; care focused on
empowering them to manage a chronic disease; or hospice care at the
end of life. More than 2,200 hospitals and 61,900 physicians
nationwide have chosen Amedisys as a partner in post-acute care.
Founded in 1982, headquartered in Baton Rouge, LA with an executive
office in Nashville, TN, Amedisys is a publicly held company. With
more than 16,000 employees, in 426 care centers in 34 states,
Amedisys is dedicated to delivering the highest quality of care to
the doorsteps of more than 385,000 patients in need every year. For
more information about the Company, please visit:
www.amedisys.com.
We use our company website as a channel of
distribution for important company information. Important
information, including press releases, investor presentations and
financial information regarding the Company is routinely posted on
and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on
our website home page. Visitors to our website can also register to
receive automated e-mail and other notifications alerting them to
when new information is made available on the Investor Relations
subpage of our website. In addition, we make available on the
Investor Relations subpage of our website (under the link "SEC
filings") free of charge our annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K, ownership
reports on Forms 3, 4 and 5 and any amendments to those reports as
soon as practicable after we electronically file such reports with
the SEC. Further, copies of our Certificate of Incorporation and
Bylaws, our Code of Ethical Business Conduct and the charters for
the Audit, Compensation, Nominating and Corporate Governance,
Quality of Care and Compliance and Ethics Committees of our Board
are also available on the Investor Relations subpage of our website
(under the link "Corporate Governance").
Contact:
Amedisys, Inc.
David Castille
Managing Director, Finance and Assistant Treasurer
855-259-2046
IR@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Sep 2023 to Sep 2024